BPGbio Announces Presentation of Preliminary Clinical Data Of Investigational BPM31510 For Primary CoQ10 Deficiency BPGbio to Present at UMDF Conference…
Basel, Switzerland – June 18, 2025 – TOLREMO therapeutics AG (TOLREMO), a clinical-stage biotechnology company developing TT125-802, a best-in-class CBP/p300 bromodomain…
GenAI platform connects design to production, resolving interoperability challenges and embedding expert logic across aerospace supply chains SANTA CLARA, Calif.,…